Surgical site infection (SSI) continues to be a significant postoperative complication after colorectal surgery. The neutrophil-to-lymphocyte ratio (NLR) is an inexpensive inflammatory marker that may help identify patients at increased risk of postoperative infection. Objective: To determine the association between preoperative NLR and surgical site infection following elective colorectal surgery. Methods: This prospective observational cohort study was conducted at Hayat Medical and Surgical Complex, Dera Ismail Khan, Pakistan, over six months. A patient sample of 172 patients who were undergoing elective colorectal surgery was assessed. Preoperative NLR was determined from a complete blood count, and patients were evaluated for SSI within 30 days after surgery. Appropriate statistical tests were used to explore associations, and univariable analysis was performed. Results: Surgical site infection occurred in 22 (12.8%) patients. Preoperative NLR was greater for patients with SSI compared to those without SSI (4.6 vs. 2.5). An NLR ≥3.5 was significantly associated with SSI (OR=9.68; 95% CI: 3.35–27.98; p<0.001), with sensitivity and specificity of 77.3% and 74.0%, respectively. Other factors associated with SSI were diabetes mellitus and longer operative duration. Conclusion: There was a relationship between the high levels of preoperative NLR and SSI after elective colorectal surgery. However, it must be confirmed by well-powered prospective studies to be used independently.
Postoperative complications include one of the most frequent and severe surgical site infections (SSI), especially after colorectal surgery.[1] It is defined as infection of the incision, deep soft tissues, or organ spaces involved during a surgical procedure.[2] Although surgery has improved, antimicrobial prophylaxis has been introduced, and perioperative care has further improved, SSI remains a significant challenge for healthcare systems.[3] Postoperative infections are especially common after colon and rectum surgery due to the high number of bacteria in the gastrointestinal tract, the risk of contamination during bowel surgery, and the difficulty of intestinal joining.[4]
Recent studies have suggested that the rate of SSI after elective colorectal surgery is between 10-25%, depending
on patient, surgical, and institutional infection prevention practices.[5] These infections can lead to various complications, such as delayed healing, extended hospital stays, higher antibiotic usage, rehospitalization, and significant healthcare costs. Epidemiological data also indicate that SSI remains a significant problem in CRC surgery. A nationwide surveillance study that included 64,074 elective colorectal procedures showed that the incidence of SSI at hospitals with preventive measures decreased from 19.6% to 7.6% for colon surgery and from 20.6% to 12.8% for rectal surgery.[6]
Likewise, a study of 229,167 colorectal surgeries revealed that the incidence of SSI after elective surgery was 6.8% versus 15.9% after emergency surgery, which again showed the impact of surgical circumstances on infectious complications after surgery.[7] The rate of SSI has decreased over time as a result of advances in infection control, but SSI is still a major clinical problem.
Neutrophil to lymphocyte ratio (NLR) is a simple, easily obtainable, and inexpensive marker of systemic inflammation and has been identified as one of these.[8] Neutrophil to lymphocyte ratio (NLR) has been identified as a simple, easily available, and inexpensive systemic inflammatory marker and has emerged. Neutrophils are a major part of the innate inflammatory response, while lymphocytes represent the adaptive immune response. An elevated NLR could be a marker of heightened systemic inflammatory activity, which may impair tissue repair after surgery and predispose to infection. Preoperative NLR has been shown to have clinical relevance in colorectal surgery in previous studies. Cooper et al. reported that the NLR was higher in patients who developed infective complications after colorectal cancer resection, with a mean NLR of 5.4 in patients with infective complications.[9]
Considering the clinical burden of SSI and the potential predictive value of systemic inflammatory markers, investigating the association between preoperative NLR and postoperative infection may provide an important opportunity to improve surgical risk assessment. In contrast to the more specialized inflammatory biomarkers, NLR is easily calculated from a standard complete blood count, and thus could be a readily available, cost-effective, and potentially useful tool, especially in resource-limited healthcare environments. However, its specific usefulness in identifying patients at risk of SSI following elective colorectal procedures requires further evaluation. Therefore, the present study aimed to determine the association between preoperative neutrophil-to-lymphocyte ratio and the development of surgical site infection following elective colorectal surgery, and to evaluate its potential role as a simple and cost-effective marker for preoperative identification of patients at increased risk of postoperative infection.
The present study was a prospective observational cohort study to investigate whether the preoperative NLR is associated with the occurrence of SSI after elective colorectal surgery. The study was carried out at Hayat Medical and Surgical Complex, Dera Ismail Khan, Pakistan, over a period of six months from 1st December 2025 till 31st May 2026.
The sample size was determined with the OpenEpi sample size calculator, version 3, estimating a single population proportion. In the last surveillance period, a previous study by Badia et al. (2025) found a surgical site infection rate of 12.8% for those who underwent rectal surgery.[6] The sample size was determined from this reported frequency, assuming a 95% confidence level, 5% absolute precision, and a design effect of 1. A minimum sample size of 172 patients was determined. The sample size was deemed adequate for estimating the expected frequency of surgical site infection with the desired precision.
Patients were recruited via a non-probability consecutive sampling technique. Patients with elective colorectal surgery during the study period were all eligible for inclusion, until sufficient numbers were obtained. Patients aged 18 years and above, of either gender, who underwent elective colorectal surgery for benign or malignant colorectal conditions were included in the study. All patients had to have a complete blood count done before surgery that included a neutrophil and lymphocyte count for calculation of neutrophil-to-lymphocyte ratio, and adequate postoperative follow-up data to evaluate surgical site infection.
Patients who had undergone emergency colorectal surgery, had evidence of any pre-existing infection at the operative site, and had haematological disorders affecting the number of neutrophils or lymphocytes were excluded. Other patients excluded were those taking systemic corticosteroids or other immunosuppressive medicines that might affect the inflammatory response. In patients with missing or incomplete laboratory information before surgery and/or absence of available postoperative data on the infection status, no final analysis was performed.
After determining the inclusion and exclusion criteria, eligible patients were identified from the surgical department. After obtaining institutional ethical clearance and informed consent, the following demographic, clinical, and operative data were documented on a structured data collection proforma. Baseline data included age, sex, BMI, smoking status, DM, pertinent comorbidities, indication for surgery, and colorectal procedure type. Full blood count was obtained from pre-operative samples taken within 24–72 hours prior to surgery. Absolute neutrophil counts and absolute lymphocyte counts were obtained and the ratio of neutrophils to lymphocytes was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count.
Both elective colorectal surgeries were performed under the supervision of the surgical team. Perioperative management, such as antibiotic prophylaxis, skin preparation, and postoperative wound care, was done as per the hospital surgical protocol. Surgical approach, procedure performed, duration of surgery, and the presence or absence of a stoma were noted. Patients were observed for surgical site infection (SSI) while in the hospital for surgery and for a maximum of 30 days after surgery. The occurrence of surgical site infection was determined based on the Centers for Disease Control and Prevention criteria and defined as superficial incisional, deep incisional or organ/space infection.[10] Diagnosis was made via clinical assessment, appropriate investigations and documentation by the treating surgical team. The patients were divided into two groups: SSI and non-SSI groups. The baseline (preoperative) NLR values and other clinical factors were then compared between the two groups. All data collected and analyzed were handled in a manner that preserved patient confidentiality.
IBM SPSS Statistics was used to enter and analyses data. Continuous variables, such as age, BMI, operative duration, or PLR were evaluated for normal distribution and then expressed as mean ± SD or median (IQR). All categorical variables such as gender, diabetes mellitus, smoking habits, surgical approach, and surgical site infection were presented as frequencies and percentages. Continuous variables were compared between patients who did and did not develop SSI using the independent-samples t-test, depending on the distribution of the data. Comparisons of categorical variables were made using the chi-square test and Fisher's exact test. Association between preoperative NLR and surgical site infection (SSI) was assessed by binary logistic regression analysis. Crude and adjusted odds ratios with 95% confidence intervals were estimated, based on clinically relevant potential confounding factors, as appropriate to the number of infection events. A p-value of less than 0.05 was considered statistically significant.
The analysis included 172 patients who underwent elective colorectal surgery, and 22 patients (12.8%) developed surgical site infection (SSI). The mean age and body mass index of patients with SSI were higher than those of patients without SSI, but these differences were not statistically significant. Diabetes mellitus was significantly associated with SSI (p=0.041), while there was no significant relationship between gender, smoking status, hypertension, and cardiovascular disease. (Table 1)
The most common reason for surgery in both groups was colorectal malignancy. There was no significant correlation between SSI and colorectal surgery type, surgical access or stoma formation. Patients with SSI, however, experienced a much longer mean operative duration compared to those without infection (188.5 ± 42.6 versus 161.2 ± 39.8 minutes; p=0.009). (Table 2)
The most common SSI was superficial incisional (59.1%), followed by deep incisional (27.3%) and organ/space infections (13.6%). The majority of infections were discovered during hospitalization (68.2%), with the remainder picked up after hospital discharge (31.8%). (Table 3)
Preoperative haematological parameters demonstrated significantly higher total leukocyte and absolute neutrophil counts among patients who developed SSI (p=0.002 and p<0.001, respectively), whereas absolute lymphocyte counts were significantly lower (p<0.001). The median preoperative NLR was also higher in the SSI group than in the non-SSI group, but was not found to be statistically significantly higher. (Table 4)
Categorical analysis revealed that there was a clear correlation between higher NLR before surgery and SSI (p<0.001). The sensitivity was 77.3%, and the specificity was 74.0%; the positive predictive value was 30.4%, and the negative predictive value was 95.7% at the assumed NLR level of 3.5. (Table 5)
Univariable analysis showed that an NLR ≥3.5 was significantly associated with increased odds of SSI (OR=9.68; 95% CI: 3.35–27.98). Diabetes mellitus was also a risk factor for SSI (OR=2.55; 95% CI: 1.02-6.34), but smoking, open surgical approach, stoma creation, and male gender were not shown to be statistically significant. These estimates were not adjusted, and independent associations were not possible without multivariable analysis. (Table 6)
Table 1. Demographic and clinical characteristics
|
Variable |
SSI (n=22) |
No SSI (n=150) |
p-value |
|
Age (years), mean ± SD |
57.8 ± 12.6 |
52.4 ± 13.8 |
0.074 |
|
BMI (kg/m²), mean ± SD |
27.6 ± 4.2 |
25.9 ± 4.0 |
0.086 |
|
Male gender |
14 (63.6%) |
96 (64.0%) |
0.974 |
|
Diabetes mellitus |
10 (45.5%) |
37 (24.7%) |
0.041 |
|
Smoking |
8 (36.4%) |
35 (23.3%) |
0.187 |
|
Hypertension |
9 (40.9%) |
42 (28.0%) |
0.216 |
|
Cardiovascular disease |
3 (13.6%) |
12 (8.0%) |
0.413 |
Table 2. Operative characteristics of patients undergoing elective colorectal surgery (n=172)
|
Variable |
SSI (n=22) |
No SSI (n=150) |
p-value |
|
Colorectal malignancy |
13 (59.1%) |
82 (54.7%) |
0.697 |
|
Benign colorectal disease |
9 (40.9%) |
68 (45.3%) |
— |
|
Surgical procedure (overall) |
|
|
0.981 |
|
Right hemicolectomy |
5 (22.7%) |
40 (26.7%) |
— |
|
Left hemicolectomy |
4 (18.2%) |
30 (20.0%) |
— |
|
Sigmoid colectomy |
5 (22.7%) |
35 (23.3%) |
— |
|
Anterior resection |
6 (27.3%) |
33 (22.0%) |
— |
|
Abdominoperineal resection |
2 (9.1%) |
12 (8.0%) |
— |
|
Open surgery |
15 (68.2%) |
70 (46.7%) |
0.059 |
|
Laparoscopic surgery |
7 (31.8%) |
80 (53.3%) |
— |
|
Stoma creation |
9 (40.9%) |
35 (23.3%) |
0.078 |
|
Operative duration (minutes), mean ± SD |
188.5 ± 42.6 |
161.2 ± 39.8 |
0.009 |
Table 3. Frequency and classification of surgical site infection within 30 postoperative days (n=172)
|
Outcome |
Frequency (n) |
Percentage (%) |
|
Surgical site infection |
22 |
12.8 |
|
No surgical site infection |
150 |
87.2 |
|
Classification among SSI cases (n=22) |
|
|
|
Superficial incisional SSI |
13 |
59.1 |
|
Deep incisional SSI |
6 |
27.3 |
|
Organ/space SSI |
3 |
13.6 |
|
Time of SSI detection (n=22) |
|
|
|
During hospital stay |
15 |
68.2 |
|
After hospital discharge |
7 |
31.8 |
|
SSI diagnosis supported by |
|
|
|
Clinical assessment only |
12 |
54.5 |
|
Clinical assessment and microbiological findings |
10 |
45.5 |
Table 4. Comparison of preoperative haematological parameters between SSI and non-SSI groups
|
Parameter |
SSI (n=22) |
No SSI (n=150) |
p-value |
|
Total leukocyte count (×10³/µL) |
9.4 ± 2.1 |
7.8 ± 1.9 |
0.002 |
|
Absolute neutrophil count (×10³/µL) |
7.1 ± 1.8 |
5.1 ± 1.4 |
<0.001 |
|
Absolute lymphocyte count (×10³/µL) |
1.5 ± 0.5 |
2.0 ± 0.6 |
<0.001 |
|
Preoperative NLR, median (IQR) |
4.6 (3.5–6.1) |
2.5 (1.8–3.4) |
|
Table 5. Association between preoperative NLR categories and surgical site infection
|
NLR category |
SSI (n=22) |
No SSI (n=150) |
p-value |
|
NLR ≥3.5 |
17 (77.3%) |
39 (26.0%) |
<0.001 |
|
NLR <3.5 |
5 (22.7%) |
111 (74.0%) |
— |
Table 6. Univariable logistic regression analysis of factors associated with surgical site infection
|
Variable |
Crude OR |
95% CI |
p-value |
|
NLR ≥3.5 |
9.68 |
3.35–27.98 |
<0.001 |
|
Diabetes mellitus |
2.55 |
1.02–6.34 |
0.041 |
|
Smoking |
1.88 |
0.73–4.82 |
0.187 |
|
Open surgery |
2.45 |
0.95–6.30 |
0.059 |
|
Stoma creation |
2.27 |
0.89–5.82 |
0.078 |
|
Male gender |
0.98 |
0.39–2.50 |
0.974 |
The study showed that rate of SSI was 12.8% after elective colorectal surgery. This incidence was generally similar to that found in the modern colorectal surgical literature, but there were significant differences among the various studies in relation to infection-prevention measures, operative techniques, and patient demographics. The observed frequency showed that, despite routine perioperative prophylaxis, SSI was still a significant postoperative problem.
The main result was that an elevated NLR before the surgery was associated with SSI after the surgery. Patients who developed SSI had higher NLR values preoperatively, and an NLR cut-off of 3.5 was correlated with higher unadjusted odds for SSI. It was a biologically plausible observation, as it was not specific for infection risk, but rather the ratio of neutrophils to lymphocytes in the circulation.
Mao et al. (2024) performed a retrospective study of 1,445 patients who underwent colorectal cancer surgery and found that derived NLR (dNLR) was one of seven factors included in a model for predicting the incidence of SSI. The model had an AUC of 0.838 and 0.793 in the training and validation cohorts, respectively. In this context, these results confirmed the role of inflammatory indices before surgery in risk assessment of SSI. However, dNLR was not conventional NLR, and the reported predictive performance was a multivariable model and not just NLR. Thus, the findings were positive towards the study hypothesis but not exactly comparable to the current association of the NLR.[11]
In a 2026 two-center retrospective study of 1331 colorectal cancer patients, similarly, there was an association between preoperative inflammatory indices and postoperative complications. After adjusting for any other influence, elevated NLR continued to be linked to complications with an odds ratio of 5.86 for the highest quartile of NLR. The AUC of the combined inflammatory-marker model was 0.792. While this followed the direction of the association, the study was not designed to measure SSI specifically, but rather all postoperative complications. Thus, the magnitude of the associations could not be directly compared with the unadjusted odds ratio of 9.68 present in this study.[12]
In 2023, a systematic review and meta-analysis of 12 studies and 4375 patients indicated that the pooled sensitivity and specificity of NLR for predicting postoperative infectious complications were 77% and 78%, respectively. These estimates were similar to the sensitivity of 77.3% and specificity of 74.0%, at an NLR threshold of 3.5. However, this review excluded various surgical techniques, sampling times, and infectious outcomes, and the authors rated the certainty of evidence as low. Therefore, these results did not define a standard NLR cut-off for elective colorectal surgery.[13]
In a second study, 206 patients with Crohn's disease were treated for elective surgery and 12.6% of patients developed septic complications within the abdomen. Preoperative NLR was an independent risk factor for these complications (OR=3.43; 95% CI: 1.30–9.04), and the optimum reported threshold was 3.98. Longer operative duration was also associated with complications. The observations were consistent with the direction of the NLR and operative-duration results. Not all intra-abdominal septic complications were the same among Crohn's disease patients; however, in the present study, a CDC-defined outcome of SSI was used.[14]
The SSI incidence of 12.8% was also comparable with some findings reported by Badia et al. (2025). They noted a decrease in SSI incidence from 19.6% to 7.6% and from 20.6% to 12.8% after colon and rectal surgery, respectively, across the surveillance periods in their nationwide surveillance study involving 64,074 elective colorectal procedures. Comparing the SSI frequencies showed that these rates were significantly different and demonstrated the impact of procedure type, surveillance, and infection-prevention programmes when comparing the rates.[6]
Sun et al. (2025) found that there were differing trends in SSI between elective and emergency surgery when analysing 229,167 colorectal operations. Surgery outcomes yielded consistent reductions in SSI rates after elective surgery, but not after emergency surgery. In line with this, the present study was limited to elective colorectal surgery procedures, which consequently minimized heterogeneity resulting from the emergency operative condition. However, there may be additional confounding factors such as the complexity of the surgery, comorbidities, and perioperative management that could have a significant impact on the risk of SSI.[7]
In a 2024 systematic review and meta-analysis of 26 studies and 61,426 patients, male sex, high BMI, and ASA classification were found to be risk factors for SSI after colorectal surgery. Minimally invasive surgery was found to have fewer odds of infection (OR=0.70). Compared with open surgery, an SSI was more common, but not statistically different (p=0.059) in the study. Likewise, there was no significant association between gender and BMI and infection. These differences may be due to the number of patients, patient selection, or operative characteristics and were not necessarily in opposition to the larger pooled evidence.[15]
In a 2025 Vietnamese observational study, 169 patients underwent colorectal surgery, and an incidence of SSI for this surgery was reported to be 6.5%. There was no lack of antibiotic prophylaxis, emergency surgery, or open surgical approach that was independently associated with SSI, but obesity was associated with SSI in univariable analyses, which was maintained following adjustment. This finding demonstrated the presence of apparent associations between individual clinical parameters and SSI that are lost when other parameters are taken into account. Diabetes was found to be associated with SSI in the present analysis after being compared to non-diabetic controls in the same manner; however, the independent effect of diabetes could not be determined without multivariable modelling.[16]
In a study from a tertiary cancer center in 2025, 28% had SSI in 712 colorectal surgery recipients. Preoperative anaemia and hypotension were significant factors increasing the risk of infection, while adequate antimicrobial prophylaxis was associated with a reduced risk of SSI. The increased infection rate was related to the study, which may have been due to case mix, operative complexity, or peri-operative factors. Importantly, these showed that SSI was multifactorial and that NLR should not be looked at in isolation of existing clinical and operative risk factors.[17]
A multicenter prospective study which was published in 2026 in Pakistan enrolled 1,711 patients for elective surgery in 28 hospitals and found that overall prevalence of SSI was 9.5%. The rates of superficial infections in the present sample (59.1%) and the superficial infections in the cases with SSI (73.6%) differ. The adjusted odds of SSI were lower for laparoscopic surgery (OR=0.556; 95% CI: 0.343–0.900). The study included surgical specialties other than colorectal surgery, but gave national context and solidified the role of the operative approach and infection prevention.[18]
The overall results were in line with previous studies that indicated that systemic inflammatory markers might be linked to poor postoperative outcomes. The studies available, however, varied in terms of their populations, timing of the measurement of the NLR, the definition of infection, and the way statistical adjustments were made. The present analysis was specifically limited by only deriving regression estimates from a single center, the small number of SSI events analyzed, the assumption of an NLR threshold, and the lack of adjusted regression estimates or patient-level ROC analysis. The relatively low frequency of SSI also contributed to the high negative predictive value, and should not be used as sufficient evidence to rule out infection. Preoperative NLR was therefore a tool that seemed potentially useful as an adjunct to clinical risk assessment, but that was not established in this study as being associated independently with SSI, nor as being a useful predictor for it.
LIMITATIONS
There were a number of limitations in this study. First, the findings were only generalizable to a relatively small sample size, and with a one-center design. Second, the limited number of patients with SSI precluded conducting a thorough multivariable analysis and adequately controlling for potential confounding factors. Third, the preoperative NLR was measured at a single time point and did not necessarily represent fluctuations in inflammatory status during the perioperative period. Moreover, NLR is not specific for inflammation and might be affected by other clinical conditions and underlying comorbidities. Additionally, the relatively short follow-up period after surgery, and the fact that there may have been some variation in how the infections were monitored, may have influenced the identification of surgical site infections. Lastly, the proposed NLR cut-off was not validated externally, which restricts the immediate clinical applications of the proposed NLR cut-off.
High levels of preoperative NLR was a risk factor for SSI in elective colorectal surgery. NLR appeared to be a promising, inexpensive, and easily available inflammatory marker preoperatively. The role of its predictive value was, however, not clear due to the small sample size and lack of adjusted analysis. Larger prospective multicenter studies are needed to confirm these data and set clinically relevant NLR cut-off values.